Pro PG receives S19 A for Bleomycin Injection (market shortage Australia) - stock available now.

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.

For current Australian shortage and supply information, see medicine shortages in Australia.

​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Bleomycin Injection until January 31st 2020.

Bleomycin Injection is currently experiencing a shortage of supply in Australia.

Product: Bleomycin Injection 15 Units S19a

Stock availability: Stock is available now at Wholesalers Nationally.

Ordering

Orders can be placed via Wholesalers Symbion and Central Healthcare Services (CHS) via the below PDE numbers.

Symbion PDE: 629103

CHS PDE: BLEI15PR

http://www.pbs.gov.au/info/news/2019/05/pbs-summary-of-changes-1-june-2019

Please click for Dear Health Care Professional Letter

Please click to see Product Information for Health Professionals